BCRX logo

BioCryst Pharmaceuticals (BCRX) Current liabilities

annual current liabilities:

$160.38M+$10.40M(+6.93%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual total current liabilities is $160.38 million, with the most recent change of +$10.40 million (+6.93%) on December 31, 2024.
  • During the last 3 years, BCRX annual current liabilities has risen by +$56.67 million (+54.63%).
  • BCRX annual current liabilities is now at all-time high.

Performance

BCRX Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly current liabilities:

$139.85M-$20.53M(-12.80%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly total current liabilities is $139.85 million, with the most recent change of -$20.53 million (-12.80%) on March 31, 2025.
  • Over the past year, BCRX quarterly current liabilities has increased by +$19.93 million (+16.62%).
  • BCRX quarterly current liabilities is now -12.80% below its all-time high of $160.38 million, reached on December 31, 2024.

Performance

BCRX quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

BCRX Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.9%+16.6%
3 y3 years+54.6%+72.6%
5 y5 years+73.7%+50.9%

BCRX Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+54.6%-12.8%+72.6%
5 y5-yearat high+73.7%-12.8%+72.6%
alltimeall timeat high>+9999.0%-12.8%>+9999.0%

BCRX Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$139.85M(-12.8%)
Dec 2024
$160.38M(+6.9%)
$160.38M(+4.4%)
Sep 2024
-
$153.57M(+19.0%)
Jun 2024
-
$129.06M(+7.6%)
Mar 2024
-
$119.92M(-20.0%)
Dec 2023
$149.99M(+42.1%)
$149.99M(+65.3%)
Sep 2023
-
$90.76M(-2.9%)
Jun 2023
-
$93.50M(+9.8%)
Mar 2023
-
$85.16M(-19.3%)
Dec 2022
$105.51M(+1.7%)
$105.51M(+29.2%)
Sep 2022
-
$81.64M(-14.4%)
Jun 2022
-
$95.39M(+17.7%)
Mar 2022
-
$81.02M(-21.9%)
Dec 2021
$103.72M(-1.8%)
$103.72M(-22.4%)
Sep 2021
-
$133.61M(+15.6%)
Jun 2021
-
$115.60M(+14.2%)
Mar 2021
-
$101.20M(-4.2%)
Dec 2020
$105.65M(+14.4%)
$105.65M(-5.5%)
Sep 2020
-
$111.78M(+8.9%)
Jun 2020
-
$102.65M(+10.7%)
Mar 2020
-
$92.70M(+0.4%)
Dec 2019
$92.33M(+32.9%)
$92.33M(+12.4%)
Sep 2019
-
$82.17M(+14.2%)
Jun 2019
-
$71.95M(+8.5%)
Mar 2019
-
$66.33M(-4.5%)
Dec 2018
$69.48M(-7.2%)
$69.48M(+8.0%)
Sep 2018
-
$64.36M(-13.2%)
Jun 2018
-
$74.17M(-1.6%)
Mar 2018
-
$75.34M(+0.7%)
Dec 2017
$74.84M(+37.7%)
$74.84M(+8.1%)
Sep 2017
-
$69.24M(+17.5%)
Jun 2017
-
$58.94M(+0.6%)
Mar 2017
-
$58.56M(+7.7%)
Dec 2016
$54.36M(-12.7%)
$54.36M(+5.5%)
Sep 2016
-
$51.52M(-8.3%)
Jun 2016
-
$56.19M(-10.9%)
Mar 2016
-
$63.07M(+1.3%)
Dec 2015
$62.26M(+8.7%)
$62.26M(-3.4%)
Sep 2015
-
$64.44M(+1.1%)
Jun 2015
-
$63.77M(+3.1%)
Mar 2015
-
$61.86M(+8.0%)
Dec 2014
$57.29M(+275.5%)
$57.29M(+15.0%)
Sep 2014
-
$49.82M(+10.9%)
Jun 2014
-
$44.94M(+228.3%)
Mar 2014
-
$13.69M(-10.3%)
Dec 2013
$15.26M(-11.4%)
$15.26M(+15.7%)
Sep 2013
-
$13.18M(+10.2%)
Jun 2013
-
$11.96M(+5.6%)
Mar 2013
-
$11.32M(-34.3%)
Dec 2012
$17.22M(-34.5%)
$17.22M(+37.1%)
Sep 2012
-
$12.56M(-34.2%)
Jun 2012
-
$19.11M(+18.2%)
Mar 2012
-
$16.16M(-38.5%)
Dec 2011
$26.30M(-6.1%)
$26.30M(+36.0%)
Sep 2011
-
$19.33M(-12.0%)
Jun 2011
-
$21.96M(+0.9%)
Mar 2011
-
$21.77M(-22.2%)
Dec 2010
$28.00M(-24.8%)
$28.00M(+38.3%)
Sep 2010
-
$20.25M(+34.1%)
Jun 2010
-
$15.10M(-28.4%)
Mar 2010
-
$21.09M(-43.4%)
Dec 2009
$37.25M
$37.25M(+110.1%)
DateAnnualQuarterly
Sep 2009
-
$17.73M(+31.7%)
Jun 2009
-
$13.46M(-0.7%)
Mar 2009
-
$13.56M(-20.7%)
Dec 2008
$17.11M(-39.2%)
$17.11M(-2.6%)
Sep 2008
-
$17.56M(+1.2%)
Jun 2008
-
$17.35M(-33.1%)
Mar 2008
-
$25.95M(-7.7%)
Dec 2007
$28.12M(+161.9%)
$28.12M(+13.7%)
Sep 2007
-
$24.73M(+44.2%)
Jun 2007
-
$17.16M(+26.3%)
Mar 2007
-
$13.58M(+26.5%)
Dec 2006
$10.73M(-5.7%)
$10.73M(-16.8%)
Sep 2006
-
$12.90M(+33.3%)
Jun 2006
-
$9.68M(-12.0%)
Mar 2006
-
$11.01M(-3.3%)
Dec 2005
$11.38M(+301.6%)
$11.38M(+230.2%)
Sep 2005
-
$3.45M(+52.5%)
Jun 2005
-
$2.26M(-15.7%)
Mar 2005
-
$2.68M(-5.3%)
Dec 2004
$2.83M(+110.2%)
$2.83M(-13.3%)
Sep 2004
-
$3.27M(+58.8%)
Jun 2004
-
$2.06M(-7.5%)
Mar 2004
-
$2.23M(+65.0%)
Dec 2003
$1.35M(+54.6%)
$1.35M(+19.2%)
Sep 2003
-
$1.13M(-12.0%)
Jun 2003
-
$1.28M(+44.9%)
Mar 2003
-
$887.00K(+1.7%)
Dec 2002
$872.00K(-56.0%)
$872.00K(-6.6%)
Sep 2002
-
$934.00K(-31.6%)
Jun 2002
-
$1.36M(-11.1%)
Mar 2002
-
$1.53M(-22.6%)
Dec 2001
$1.98M(-51.9%)
$1.98M(+147.8%)
Sep 2001
-
$800.00K(-80.5%)
Jun 2001
-
$4.10M(+20.7%)
Mar 2001
-
$3.40M(-17.6%)
Dec 2000
$4.12M(+142.5%)
$4.12M(+342.3%)
Sep 2000
-
$932.00K(-38.8%)
Jun 2000
-
$1.52M(+16.9%)
Mar 2000
-
$1.30M(-23.3%)
Dec 1999
$1.70M(+54.5%)
$1.70M(+41.7%)
Sep 1999
-
$1.20M(+20.0%)
Jun 1999
-
$1.00M(+11.1%)
Mar 1999
-
$900.00K(-18.2%)
Dec 1998
$1.10M(+22.2%)
$1.10M(-26.7%)
Sep 1998
-
$1.50M(+36.4%)
Jun 1998
-
$1.10M(-21.4%)
Mar 1998
-
$1.40M(+55.6%)
Dec 1997
$900.00K(-35.7%)
$900.00K(-25.0%)
Sep 1997
-
$1.20M(-14.3%)
Jun 1997
-
$1.40M(+7.7%)
Mar 1997
-
$1.30M(-7.1%)
Dec 1996
$1.40M(+27.3%)
$1.40M(+16.7%)
Sep 1996
-
$1.20M(-14.3%)
Jun 1996
-
$1.40M(+27.3%)
Mar 1996
-
$1.10M(0.0%)
Dec 1995
$1.10M(+37.5%)
$1.10M(+57.1%)
Sep 1995
-
$700.00K(-12.5%)
Jun 1995
-
$800.00K(+33.3%)
Mar 1995
-
$600.00K(-25.0%)
Dec 1994
$800.00K
$800.00K(+14.3%)
Sep 1994
-
$700.00K(-46.2%)
Jun 1994
-
$1.30M(-7.1%)
Mar 1994
-
$1.40M

FAQ

  • What is BioCryst Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual current liabilities year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly current liabilities year-on-year change?

What is BioCryst Pharmaceuticals annual total current liabilities?

The current annual current liabilities of BCRX is $160.38M

What is the all time high annual current liabilities for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual total current liabilities is $160.38M

What is BioCryst Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, BCRX annual total current liabilities has changed by +$10.40M (+6.93%)

What is BioCryst Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of BCRX is $139.85M

What is the all time high quarterly current liabilities for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly total current liabilities is $160.38M

What is BioCryst Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, BCRX quarterly total current liabilities has changed by +$19.93M (+16.62%)
On this page